I think you're right about results. I suspect biotech traders are going to start piling in as we approach early November. The next four months are momentous.
I posed a question to Art some time ago. I said wouldn’t it make the most sense to just have one partner with the whole Brilacidin platform. He answered yes. We discussed the advertising issue and off label uses. It would be difficult to have multiple partners. Remember he agreed to”make the most sense”. Nothing definite
News 
Market Data 
Discover 
